Internal Medicine · Hayti, MO
NPI
1477660637
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
223 S 3rd St
Hayti, MO, 63851
Phone (573) 559-3591
Groups this clinician bills Medicare through
Medicare paid, 2024
$567K
12,775 services
Medicare patients, 2024
1,011
Average age 67
Drug cost, 2024
$5.4M
59,393 prescriptions
Company payments, 2025
$1,796
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdullah Arshad was code 99490 (chronic, principal, and transitional care management), 1,677 times for 514 patients. In total Abdullah Arshad billed 12,775 services in 200 codes, and Medicare paid $567K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,677 | 514 | $35.70 | $60K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 975 | 15 | $0.09 | $88.12 |
| 95004 Test - Miscellaneous | Office | 793 | 12 | $2.38 | $1,887 |
| 95816 Neurologic | Office | 752 | 62 | $249.47 | $188K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 636 | 290 | $21.43 | $14K |
| 96112 Behavioral Health Services | Office | 622 | 62 | $88.65 | $55K |
| 90901 Behavioral Health Services | Office | 551 | 50 | $26.56 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 545 | 170 | $54.71 | $30K |
| 99214 Office E&M - Established | Office | 364 | 164 | $72.76 | $26K |
| 99457 E&M - Miscellaneous | Office | 331 | 107 | $30.83 | $10K |
| 99238 Hospital Discharge Management | Facility | 282 | 216 | $55.86 | $16K |
| 99458 E&M - Miscellaneous | Office | 258 | 88 | $25.27 | $6,521 |
| 85025 Blood Count | Office | 214 | 185 | $7.61 | $1,629 |
| 99454 E&M - Miscellaneous | Office | 206 | 77 | $28.53 | $5,876 |
| 84443 Clinical Chemistry | Office | 197 | 181 | $16.46 | $3,243 |
By year: 2022 $721K for 29,019 services; 2023 $1.1M for 61,163 services; 2024 $567K for 12,775 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 214 | 185 | $7.61 | $1,629 |
| 84443 Clinical Chemistry | 197 | 181 | $16.46 | $3,243 |
| 80053 Clinical Chemistry | 197 | 179 | $10.35 | $2,039 |
| 80061 Clinical Chemistry | 174 | 160 | $13.04 | $2,270 |
| 36415 Venipuncture Blood Collection | 119 | 107 | $8.65 | $1,029 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 37 | 29 | $235.68 | $8,720 |
| 82306 Clinical Chemistry | 32 | 28 | $26.86 | $860 |
| 84439 Clinical Chemistry | 29 | 28 | $8.84 | $256 |
| 84153 Clinical Chemistry | 24 | 22 | $18.02 | $432 |
| 81002 Clinical Chemistry | 16 | 13 | $3.41 | $54.56 |
Medicare prescription drug claims, 2024
In 2024, the drug Abdullah Arshad prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,594 prescriptions and refills. In total Abdullah Arshad wrote 59,393 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,594 | 2,767 | 573 | $17K |
| Pantoprazole Sodium Generic | 1,924 | 2,026 | 420 | $14K |
| Amlodipine Besylate Generic | 1,496 | 1,591 | 347 | $6,094 |
| Levothyroxine Sodium Generic | 1,477 | 1,570 | 321 | $13K |
| Gabapentin Generic | 1,410 | 1,469 | 386 | $18K |
| Furosemide Generic | 1,351 | 1,400 | 329 | $6,829 |
| Potassium Chloride Generic | 1,332 | 1,368 | 290 | $26K |
| Lisinopril Generic | 1,253 | 1,353 | 331 | $6,242 |
| Metformin Hcl Generic | 1,039 | 1,075 | 265 | $6,191 |
| Clopidogrel Clopidogrel Bisulfate | 922 | 960 | 179 | $6,179 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 839 | 890 | 297 | $21K |
| Eliquis Apixaban | 813 | 825 | 126 | $279K |
| Alprazolam Generic | 805 | 805 | 211 | $3,683 |
| Trazodone Hcl Generic | 796 | 827 | 206 | $5,291 |
| Metoprolol Tartrate Generic | 790 | 861 | 185 | $4,438 |
Brand drugs: 8,351 claims; generic drugs: 50,165 claims; opioid claims: 1,437.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdullah Arshad $1,796 ($1,796 in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Pharmaceuticals, Inc with $754.
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc JNJ | 1 | $754 |
| Alkermes, Inc. ALKS | 16 | $322 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $119 |
| Lundbeck LLC | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $84.6 |
| Dexcom, Inc. DXCM | 4 | $75.41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75.4 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $59.48 |
| Amgen Inc. AMGN | 2 | $34.27 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $32.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.